Autoantibodies to a collagen-specific molecular chaperone, heat-shock protein 47, in systemic sclerosis

Clinical and Experimental Immunology

Volumn 138, Issue 3, 2004, Pages 534-539

  Fujimoto, M ^a,c   Hamaguchi, Y ^b   Yazawa, N ^a   Komura, K ^b   Takehara, K ^b   Sato, S ^b  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Autoimmunity; Scleroderma; Stress protein; Tight skin mouse

Indexed keywords

AUTOANTIBODY; CHAPERONE; COLLAGEN; HEAT SHOCK PROTEIN 47; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2; PENICILLAMINE; PREDNISOLONE;

ADOLESCENT; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; COLLAGEN METABOLISM; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; HUMAN; IMMUNOBLOTTING; KELOID; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; AGED; ANIMALS; AUTOANTIBODIES; CHILD; DERMATOMYOSITIS; FEMALE; HEAT-SHOCK PROTEINS; HSP47 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KELOID; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MRL LPR; MIDDLE AGED; SCLERODERMA, SYSTEMIC; SERPINS;

EID: 9644275225     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02633.x     Document Type: Article

References (34)

1. Jimenez SA, Hitraya E, Varga J. Pathogenesis of scleroderma. Collagen. Rheum Dis Clin North Am 1996; 22:647-74.
2. Sato S. Abnormalities of adhesion molecules and chemokines in scleroderma. Curr Opin Rheumatol 1999; 11:503-7.
3. Hightower LE. Heat shock, stress proteins, chaperones, and proteotoxicity. Cell 1991; 66:191-7.
4. Nagata K. Hsp47: a collagen-specific molecular chaperone. Trends Biochem Sci 1996; 21:22-6.
5. Nagai N, Hosokawa M, Itohara S et al. Embryonic lethality of molecular chaperone hsp47 knockout mice is associated with defects in collagen biosynthesis. J Cell Biol 2000; 150:1499-506.
6. Kawada N, Kuroki T, Kobayashi K et al. Expression of heat-shock protein 47 in mouse liver. Cell Tissue Res 1996; 284:341-6.
7. Razzaque MS, Hossain MA, Kohno S, Taguchi T. Bleomycin-induced pulmonary fibrosis in rat is associated with increased expression of collagen-binding heat shock protein (HSP) 47. Virchows Arch 1998; 432:455-60.
8. Razzaque MS, Nazneen A, Taguchi T. Immunolocalization of collagen and collagen-binding heat shock protein 47 in fibrotic lung diseases. Mod Pathol 1998; 11:1183-8.
9. Kuroda K, Tsukifuji R, Shinkai H. Increased expression of heat-shock protein 47 is associated with overproduction of type I procollagen in systemic sclerosis skin fibroblasts. J Invest Dermatol 1998; 111:1023-8.
10. Atamas SP, White B. Interleukin 4 in systemic sclerosis: not just an increase. Clin Diagn Lab Immunol 1999; 6:658-9.
11. Denton CP, Abraham DJ. Transforming growth factor-beta and connective tissue growth factor: key cytokines in scleroderma pathogenesis. Curr Opin Rheumatol 2001; 13:505-11.
12. Simms RW, Korn JH. Cytokine directed therapy in scleroderma: rationale, current status, and the future. Curr Opin Rheumatol 2002; 14:717-22.
13. Takehara K. Hypothesis: pathogenesis of systemic sclerosis. J Rheumatol 2003; 30:755-9.
14. Gallucci S, Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol 2001; 13:114-9.
15. Winfield J, Jarjour W. Stress proteins in autoimmunity. Adv Exp Med Biol 1994; 347:99-113.
16. Okano Y. Antinuclear antibody in systemic sclerosis (scleroderma). Rheum Dis Clin North Am 1996; 22:709-35.
17. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23:581-90.
18. LeRoy EC, Black C, Fleischmajer R et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15:202-5.
19. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271-7.
20. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292:344-7.
21. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975; 292:403-7.
22. Steen VD, Powell DL, Medsger TAJ. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 1988; 31:196-203.
23. Fujimoto M, Poe JC, Satterthwaite AB, Wahl MI, Witte ON, Tedder TF. Complementary roles for CD19 and Bruton's tyrosine kinase in B lymphocyte signal transduction. J Immunol 2002; 168:5465-76.
24. Sato S, Hasegawa M, Fujimoto M, Tedder TF, Takehara K. Quantitative genetic variation in CD19 expression correlates with autoimmunity. J Immunol 2000; 165:6635-43.
25. Green MC, Sweet HO, Bunker LE. Tight-skin, a new mutation of the mouse causing excessive growth of connective tissue and skeleton. Am J Pathol 1976; 82:493-512.
26. Yokota S, Kubota H, Matsuoka Y et al. Prevalence of HSP47 antigen and autoantibodies to HSP47 in the sera of patients with mixed connective tissue disease. Biochem Biophys Res Commun 2003; 303:413-8.
27. Kielty CM, Raghunath M, Siracusa LD et al. The tight skin mouse: demonstration of mutant fibrillin-1 production and assembly into abnormal microfibrils. J Cell Biol 1998; 140:1159-66.
28. Bona C, Rothfield N. Autoantibodies in scleroderma and tightskin mice. Curr Opin Immunol 1994; 6:931-7.
29. Murai C, Saito S, Kasturi KN, Bona CA. Spontaneous occurrence of anti-fibrillin-1 autoantibodies in tight-skin mice. Autoimmunity 1998; 28:151-5.
30. Tan FK, Arnett FC, Antohi S et al. Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin-1, in patients with scleroderma and other connective tissue diseases. J Immunol 1999; 163:1066-72.
31. Eggleton P, Llewellyn DH. Pathophysiological roles of calreticulin in autoimmune disease. Scand J Immunol 1999; 49:466-73.
32. Howard ONZ, Dong HF, Yang D et al. Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells. J Exp Med 2002; 196:781-91.
33. Sato S, Hayakawa I, Hasegawa M, Fujimoto M, Takehara K. Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis. J Invest Dermatol 2003; 120:542-7.
34. Zhou X, Tan FK, Bona CA, Wallis D, Milewicz DM, Arnett FC. Antifibrillin-1 autoantibodies induce increased gene expression of FBN1 in normal dermal fibroblasts. Arthritis Rheum 2001; 44:S194.